英矽智能：12月30日上市，拟筹资22.8亿港元

Core Viewpoint - The company, Insilico Medicine, plans to raise approximately HKD 2.28 billion through an IPO in Hong Kong, with shares priced at HKD 24.05 each, and is set to list on December 30 [1] Group 1 - Insilico Medicine will issue around 95 million shares in the upcoming IPO [1] - The joint sponsors for the IPO are Morgan Stanley, CICC, and GF Securities [1] - The company utilizes its Pharma.AI platform to accelerate drug discovery in the biotechnology sector [1]